Full data view for gene MUTYH


Information The variants shown are described using the NM_001128425.1 transcript reference sequence.

13 entries on 1 page. Showing entries 1 - 13.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
?/. _1 c.-216-3949T>C r.(=) p.(=) - Unknown - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 - DUPLICATE – to be removed - rs9429072 Germline - - - 0 - - - - - - - - - - - - - - - - - - -
?/. _1 c.-216-3949T>C r.(=) p.(=) - Unknown - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 625/2520=24.8% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) cancer, prostate - PubMed: Agalliu 2009 455/1260 (36.1%) heterozygotes among Caucasian prostate cancer patients (85 homozygotes) M - United States white - 0 - - 455 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Parent #1 - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 625/2520=24.8% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) cancer, prostate - PubMed: Agalliu 2009 85/1260 (6.8%) homozygotes among Caucasian prostate cancer patients (455 heterozygotes) M - United States white - 0 - - 85 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Parent #2 - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 625/2520=24.8% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) cancer, prostate - PubMed: Agalliu 2009 85/1260 (6.8%) homozygotes among Caucasian prostate cancer patients (455 heterozygotes) M - United States white - 0 - - 85 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Unknown - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 151/290=52.1% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) cancer, prostate - PubMed: Agalliu 2009 71/145 (49.0%) heterozygotes among African-American prostate cancer patients (40 homozygotes) M - United States African-American - 0 - - 71 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Parent #1 - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 151/290=52.1% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) cancer, prostate - PubMed: Agalliu 2009 40/145 (27.6%) homozygotes among African-American prostate cancer patients (71 heterozygotes) M - United States African-American - 0 - - 40 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Parent #2 - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 151/290=52.1% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) cancer, prostate - PubMed: Agalliu 2009 40/145 (27.6%) homozygotes among African-American prostate cancer patients (71 heterozygotes) M - United States African-American - 0 - - 40 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Unknown - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 637/2494=25.5% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) ? - PubMed: Agalliu 2009 485/1247 (38.9%) heterozygotes among Caucasian controls (76 homozygotes) M - United States white - 0 - - 485 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Parent #1 - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 637/2494=25.5% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) ? - PubMed: Agalliu 2009 76/1247 (6.1%) homozygotes among Caucasian controls (485 heterozygotes) M - United States white - 0 - - 76 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Parent #2 - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 637/2494=25.5% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) ? - PubMed: Agalliu 2009 76/1247 (6.1%) homozygotes among Caucasian controls (485 heterozygotes) M - United States white - 0 - - 76 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Unknown - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 78/158=49.4% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) ? - PubMed: Agalliu 2009 32/79 (40.5%) heterozygotes among African-American controls (23 homozygotes) M - United States African-American - 0 - - 32 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Parent #1 - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 78/158=49.4% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) ? - PubMed: Agalliu 2009 23/79 (29.1%) homozygotes among African-American controls (32 heterozygotes) M - United States African-American - 0 - - 23 Astrid Out
?/. _1 c.-216-3949T>C r.(=) p.(=) - Parent #2 - VUS g.45810091A>G g.45344419A>G - - MUTYH_000039 NM_001128425.1(MUTYH): c.-216-3949T>C; NG_008189.1(MUTYH):g.1052T>C; NM_007170.2(TESK2):c.*421T>C; NT_032977.8:g.15782009A>G PubMed: Agalliu 2009 - rs9429072 Unknown - 78/158=49.4% - 0 - DNA SEQ leukocyte allelic discrimination, test known variant (group) ? - PubMed: Agalliu 2009 23/79 (29.1%) homozygotes among African-American controls (32 heterozygotes) M - United States African-American - 0 - - 23 Astrid Out
Legend   How to query